High frequency of BRAF mutations in primary mucinous ovarian carcinoma of Taiwanese patients
Objective: Considering the clinical evidence of BRAF inhibitors that can treat melanoma patients successfully, we aimed to investigate the status of BRAF mutations of primary mucinous ovarian carcinomas (MOC) in Taiwanese women, and apply the emerging paradigm classification of BRAF mutation groups....
Saved in:
Main Authors: | Wan-Ru Chao (Author), Yi-Ju Lee (Author), Ming-Yung Lee (Author), Gwo-Tarng Sheu (Author), Chih-Ping Han (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The status of KRAS mutations in primary ovarian clear cell carcinoma: An analysis of 17 Taiwanese patients
by: Pi-Chieh Wang, et al.
Published: (2023) -
Absence of PIK3CA mutation in primary mucinous ovarian carcinoma: An analysis of 20 Taiwanese cases by FemtoPath PIK3CA mutation screen kit
by: Wan-Ru Chao, et al.
Published: (2022) -
The Her2 gene aberrations in mucinous ovarian carcinoma: Analysis of twenty-one cases
by: Hsiu-Hsiu Chiu, et al.
Published: (2020) -
Mutational analysis of PDGFRA oncogene in high-grade neuroendocrine carcinoma of the uterine cervix in twelve Taiwanese women
by: Kuang-Leei Chang, et al.
Published: (2024) -
BRAF mutational analysis in ovarian tumors: recent perspectives
by: Wong KK, et al.
Published: (2015)